Migril® tablets update
UPDATE: Migril® tablets (Oct 16)
Wockhardt UK are pleased to advise the required technology transfer process has now been successfully completed and that production of Migril® tablets (ergotamine, cyclizine, caffeine) has now commenced. This is a positive step forward, however, there still remain a number of logistical and quality assessments before supply to the market can commence.
Wockhardt would like to again apologise for the non-availability of Migril® and for any inconvenience this may be causing patients. We will continue to work hard on this and we anticipate a return to supply the product by December 2016.
Further supply updates will be posted here as and when they become available.
Go to News Page